Skip to content

PHARMACIE FIORE

Active
Private limited companyfounded 1973active for 53 yearsPlace du Marché 10, 4800 Verviers, BelgiumKBO/BCE: BE 0413.622.351
Summary

PHARMACIE FIORE has been active since 1973 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €452,803 and a net result of €188,106. Equity has been growing by about 6.1% per year since 2019. Its solvency ranks better than 64% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
PHARMACIE FIOREActiveChecked score 96/100
Risk analysis ReportCompare

Overview

Official details

Source: KBO
Status
Active since 04-10-1973 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.008.962.248 4800 Verviers, since 01-10-1973
Financial year end
31 December
Peppol
Reachable since 08-10-2025
Company details

Board and ownership

Board
  • FIANNCIERE SJSFDirector · since 05-05-2021
  • FINANCIERE DE VERVIERSDirector · permanent representative Sarah Fiore
Shareholders
Board & ownership

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€411,085
▲ 1.5%
Turnover
≈ €1.5m
estimated
Profit
€188,106
▲ 26.0%
Equity
€452,803
▲ 9.2%
Total assets
€899,573
▼ 1.7%
Employees on 31-12-2025
6
=
Financials
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskFounded in 1973Liquidity: current ratio 2.32, cash €142,887Equity €452,803 (50.3% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 66% of micro companies in retail trade (NACE 47)
Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Strong
Solvency 75+5
equity 50.3% of total assets
Liquidity 50+6
short-term debt 42.4% · cash 15.9%
Profitability 95+6
return on assets 20.9%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026lowest value 11-2026: 0.1%● unchanged vs 10-2026lowest value
Credit of up to €40,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.32 (2.29 in 2024), above the usual 1.5. Short-term debt is 42.4% and cash 15.9% of total assets. 49.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 65% of them on solvency, 50% on liquidity, 89% on profitability and 59% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Founded in 1973
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Liquidity: current ratio 2.32, cash €142,887
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Equity €452,803 (50.3% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-07-2026, 22 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
22 days early
2024
14 days early
2023
30 days late
2022
30 days late
2021
30 days late
2020
27 days late
2019
98 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 26 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 August (4 of the last 5 accounts filed within 44 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 87% of companies in retail tradesector median €27,601 · 12,764 companies €188,106 View
  • Positive: 5 profitable years in a rowprofit 2025: €188,106 5 years View

Recent changes

  1. · Gazette deed Appointment: Financière de Verviers (director)Permanent representative: Sarah Fiore
All 14 events

Companies linked to PHARMACIE FIORE

Comparable companies

These companies have the same main activity as PHARMACIE FIORE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €689,000 and €900,000, founded between 1968 and 1984.

CompanyTotal assetsGross margin
PHARMACIE FIORE Verviers€899,573€411,085
PHARMACIE PIERRE WAGNER Anthisnes€804,671€378,694
PHARMACIE C. PIRON Liège€900,485€376,767
Apotheek DE ZWAANTJES Malle€806,062€396,897
Geassocieerde Apotheek Plantijn Antwerpen€837,120€355,736
Pharmacie BODARD Marche-en-Famenne€834,959€439,338
Pharmacie Jean-Louis Barbarin Lasne€689,157€398,035
Full comparison

Key facts about PHARMACIE FIORE
What is the company number of PHARMACIE FIORE?
The company number of PHARMACIE FIORE is 0413.622.351. The VAT number is the same number with BE in front: BE 0413.622.351.
Where is PHARMACIE FIORE based?
The registered office is at Place du Marché 10, 4800 Verviers.Company details
What does PHARMACIE FIORE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE FIORE?
The legal form of PHARMACIE FIORE is Private limited company (BV).
When was PHARMACIE FIORE founded?
PHARMACIE FIORE was founded on 04-10-1973.
Is PHARMACIE FIORE still active?
Yes, PHARMACIE FIORE is an active enterprise in the KBO register.
How many employees does PHARMACIE FIORE have?
PHARMACIE FIORE had an average of 4.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMACIE FIORE?
The turnover in financial year 2025 is ≈ €1.5m. This figure is estimated from the gross margin of €411,085 and 47 comparable companies (NACE 477). It probably lies between €1.2m and €2.5m.
Is PHARMACIE FIORE profitable?
In financial year 2025, PHARMACIE FIORE made a profit of €188,106.
Where can I find the annual accounts of PHARMACIE FIORE?
PHARMACIE FIORE filed 47 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE FIORE due?
PHARMACIE FIORE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure